Patent · US Active

TAK1 kinase inhibitors, compositions, and uses related thereto

US10093609B2 · kind B2 · utility

0Cited by

3References

17Claims

0Family size

Assignee

EMORY UNIVERSITY · US

Inventors

Huw M. L. Davies · East Amherst, US
Spandan Chennamadhavuni · Natick, US
Andrei Bakin · Buffalo, US

Key dates

Filing date	Sep 4, 2017
Grant date	Oct 9, 2018
Priority date	—
Expiry date	Sep 4, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D319/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates to TAK1 inhibitors, compositions, and uses related thereto. In certain embodiments, the disclosure relates to compounds of formula I, pharmaceutical compositions having a compound of formula I, and methods of treating or preventing cancer by administering an effective amount of a pharmaceutical composition having a compound of formula I to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.